Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)
Clinical trial NCT00440531 · COMPLETED
Trial details
- NCT number
- NCT00440531
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2007-11-01
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.